Thankfully somebody has put petrol into SLA's tank, to get the engine running again.
I was surprised to see that revenue is quite respectable, but losses, liabilities and dilution of shares are still pretty bad.
As for sales, nobody has yet explained why Bioeffective A, and other products, are not for sale on the shelves of chemists and supermarkets. I have banged on about this for years. It has nothing to do with their classification by the Therapeutic Goods Administration. Self-strangulation of sales, in the name of misplaced medical pride, is the only explanation I can think of.
SLA Price at posting:
3.9¢ Sentiment: None Disclosure: Not Held